INCLUSIVENESS TARGET COUNTRIES (ITC) CONFERENCE GRANTS AVAILABLE There is now the possibility to apply for ITC conference grants if you are an investigator/innovator < 40 years old and from an Inclusiveness Target Country or Near Neighbour Country. You must present your own work as an oral or poster presentation, and the work should be related to the topic of ENOVAT …
View Post
Please check them here. The last publication was led by Professor Ludovic Pelligand on a prospective clinical trial in normal and critically ill dogs to evaluate the pharmacokinetics (PK) of intravenous amoxicillin combined with clavulanic acid. The authors checked a total of 218 amoxicillin concentrations (AMC) in plasma for healthy and sick dogs and found that the PK of AMC …
View Post
Mead Andrew, Richez Pascal, Azzariti Stefano, Pelligand Ludovic. Frontiers in Veterinary Science 2021. DOI=10.3389/fvets.2021.698135
View Post
Vegas Cómitre Maria D., Cortellini Stefano, Cherlet Marc, Devreese Mathias, Roques Beatrice B., Bousquet-Melou Alain, Toutain Pierre-Louis, Pelligand Ludovic. Frontiers in Veterinary Science 2021. DOI=10.3389/fvets.2021.770202
View Post
Temmerman R, Pelligand L, Schelstraete W, Antonissen G, Garmyn A, Devreese M. Antibiotics. 2021; 10(5):604. https://doi.org/10.3390/antibiotics10050604
View Post
ENOVAT WG1 is announcing the launch of the Antimicrobial Use Guidelines Survey which is building on the findings of the WG1’s Treatment Guidelines pilot survey. The current version is a small-animal focused survey and is hoped that it will provide an insight into how antimicrobial use guidelines are viewed by companion animal vets across Europe. This information will enable any …
View Post
We are looking for your inputs! In the framework of the COST Action ENOVAT we are working on the optimisation of MALDI TOF MS methods for bacteria that are difficult to identify using this method. We would therefore like to ask you which bacterial species/genera you still have problems identifying with MALDI TOF MS technology and for which you are …
View Post
Dear All, I hope everyone is safe and sound considering the increasing number of COVID-19 cases almost everywhere. This newsletter contains various updates from ENOVAT, including from four of the working groups. We are now halfway through ENOVAT (believe it or not!), and we are doing pretty well in terms of attaining the goals we set. A few deliverables have …
View Post
Working Group 1 Work in WG1 continues on both the diagnostic procedures and treatment guidelines surveys. The Diagnostic procedures survey which aims to review and evaluate the methodology and interpretive criteria used by veterinary diagnostic laboratories across Europe for pathogen identification and antimicrobial susceptibility testing, is now completed. The survey was taken by 290 respondents (veterinary microbiology laboratories) from 35 …
View Post
Dr. Menezes pointed out that PETS CAN PASS GENES FOR ANTIBIOTIC RESISTANCE TO HUMAN INFECTIONS “I am a PhD student at the Faculty of Veterinary Medicine of the University of Lisbon. I do my research at the Centre for Interdisciplinary Research in Animal Health under the Supervision of Professor Constança Pomba, the head of the Antibiotic Resistance Lab. The Idea …
View Post